AstraZeneca (AZNCF) Stock Chart & Stock Price History $133.93 +7.87 (+6.24%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisChartDividendFinancialsHeadlinesOwnershipSEC FilingsShort Interest AstraZeneca Stock Price Performance 5 Day Performance+6.28%1 Month Performance-11.71%3 Month Performance-21.01%6 Month Performance-15.83%Year-To-Date Performance-0.39%1 Year Performance+4.19% Receive AZNCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. Email Address Free Ebook shares Tesla’s roadmap to $500 a share (Ad)Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link AZNCF Stock Chart for Sunday, November, 24, 2024 AZNCF Chart by TradingView AstraZeneca Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$126.06$133.93+6.24%$133.93$129.551,594 shs$0.0011/21/2024$124.70$126.06+1.09%$127.22$125.502,434 shs$0.0011/20/2024$126.02$124.70-1.05%$126.75$124.402,088 shs$0.0011/19/2024$125.46$126.02+0.45%$126.32$125.721,128 shs$0.0011/18/2024$127.96$125.46-1.95%$128.60$120.642,356 shs$0.0011/15/2024$130.24$127.96-1.75%$128.70$124.552,494 shs$0.00 Get the Latest News and Ratings for AZNCF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$129.20$130.24+0.81%$132.78$129.701,697 shs$0.0011/13/2024$128.41$129.20+0.61%$129.20$129.202,353 shs$0.0011/12/2024$126.80$128.41+1.27%$129.92$126.091,186 shs$0.0011/11/2024N/A$126.80$126.80$124.682,352 shs$0.0011/08/2024$126.56$127.74+0.94%$130.06$123.851,134 shs$0.0011/07/2024$126.54$126.56+0.01%$126.56$121.312,119 shs$0.0011/06/2024$131.04$126.54-3.43%$128.00$125.901,693 shs$0.0011/05/2024$142.43$131.04-8.00%$137.10$130.332,271 shs$0.0011/04/2024$142.85$142.43-0.29%$143.11$141.421,212 shs$0.0011/01/2024$141.90$142.85+0.67%$142.85$142.20775 shs$0.0010/31/2024$149.50$141.90-5.08%$144.05$141.901,307 shs$0.0010/30/2024$149.65$149.50-0.10%$149.50$143.005,048 shs$0.0010/29/2024$148.60$149.65+0.71%$149.65$149.65500 shs$0.0010/28/2024$148.60$148.60$148.60$148.601,100 shs$0.0010/25/2024$151.70$148.60-2.04%$148.60$148.601,193 shs$0.0010/24/2024$152.34$151.70-0.42%$152.50$151.70930 shs$0.0010/23/2024$156.40$152.34-2.60%$157.15$152.341,553 shs$0.00 Related Companies 180 Life Sciences Stock Chart 4D pharma Stock Chart 4Front Ventures Stock Chart Abattis Bioceuticals Stock Chart Aeolus Pharmaceuticals Stock Chart Aesther Healthcare Acquisition Stock Chart Agentix Stock Chart Ainos Stock Chart Algernon Pharmaceuticals Stock Chart Allstar Health Brands Stock Chart Receive AZNCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:AZNCF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
